Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for HYPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 50.72%
March 31, 2026 50.70%
December 31, 2025 50.90%
September 30, 2025 53.77%
June 30, 2025 49.26%
March 31, 2025 41.32%
December 31, 2024 35.59%
September 30, 2024 52.37%
June 30, 2024 49.66%
March 31, 2024 41.09%
December 31, 2023 38.50%
September 30, 2023 48.24%
Date Value
June 30, 2023 42.71%
March 31, 2023 43.83%
December 31, 2022 21.07%
September 30, 2022 29.30%
June 30, 2022 -10.76%
March 31, 2022 5.57%
December 31, 2021 -103.9%
September 30, 2021 -91.11%
June 30, 2021 -27.65%
March 31, 2021 -83.69%
December 31, 2020 -94.69%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics